BERTEOTTI, MARTINA
 Distribuzione geografica
Continente #
NA - Nord America 2.612
AS - Asia 2.256
EU - Europa 2.172
SA - Sud America 340
AF - Africa 54
OC - Oceania 22
Continente sconosciuto - Info sul continente non disponibili 2
Totale 7.458
Nazione #
US - Stati Uniti d'America 2.540
RU - Federazione Russa 763
IT - Italia 750
SG - Singapore 635
CN - Cina 588
BR - Brasile 262
VN - Vietnam 235
HK - Hong Kong 223
KR - Corea 174
DE - Germania 135
BD - Bangladesh 118
IE - Irlanda 111
SE - Svezia 88
FR - Francia 71
IN - India 69
PL - Polonia 60
FI - Finlandia 58
JP - Giappone 46
NL - Olanda 39
AR - Argentina 37
CA - Canada 36
JO - Giordania 35
ID - Indonesia 33
GB - Regno Unito 32
MX - Messico 23
AU - Australia 22
IQ - Iraq 18
EC - Ecuador 14
NG - Nigeria 13
TR - Turchia 13
ES - Italia 10
PK - Pakistan 10
SA - Arabia Saudita 9
UA - Ucraina 9
ZA - Sudafrica 9
BE - Belgio 8
CO - Colombia 8
EG - Egitto 8
MA - Marocco 7
TW - Taiwan 7
CI - Costa d'Avorio 6
PE - Perù 6
UZ - Uzbekistan 6
NP - Nepal 5
SK - Slovacchia (Repubblica Slovacca) 5
AT - Austria 4
GE - Georgia 4
JM - Giamaica 4
NO - Norvegia 4
PY - Paraguay 4
AE - Emirati Arabi Uniti 3
CH - Svizzera 3
DK - Danimarca 3
EE - Estonia 3
IR - Iran 3
LT - Lituania 3
MY - Malesia 3
PH - Filippine 3
TN - Tunisia 3
TT - Trinidad e Tobago 3
UY - Uruguay 3
VE - Venezuela 3
BJ - Benin 2
BY - Bielorussia 2
CL - Cile 2
DZ - Algeria 2
GR - Grecia 2
KE - Kenya 2
KH - Cambogia 2
LK - Sri Lanka 2
OM - Oman 2
PA - Panama 2
RO - Romania 2
SI - Slovenia 2
AL - Albania 1
AZ - Azerbaigian 1
BH - Bahrain 1
BO - Bolivia 1
CR - Costa Rica 1
CY - Cipro 1
CZ - Repubblica Ceca 1
DO - Repubblica Dominicana 1
EU - Europa 1
HU - Ungheria 1
KN - Saint Kitts e Nevis 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
LV - Lettonia 1
MD - Moldavia 1
MM - Myanmar 1
PS - Palestinian Territory 1
SC - Seychelles 1
SN - Senegal 1
SV - El Salvador 1
TH - Thailandia 1
TJ - Tagikistan 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 7.458
Città #
Santa Clara 710
Singapore 466
Ashburn 369
Hong Kong 203
Hefei 189
San Jose 178
Seoul 172
Milan 130
Dublin 111
Florence 99
Ho Chi Minh City 89
Chandler 80
Munich 80
Fairfield 77
Beijing 73
Los Angeles 65
Hanoi 57
Warsaw 52
Rome 50
Moscow 48
New York 48
Dallas 45
Lauterbourg 45
Tokyo 42
Council Bluffs 39
Buffalo 38
The Dalles 38
Altamura 34
Houston 34
Lawrence 34
Kent 33
Cambridge 31
Frankfurt am Main 30
Mumbai 30
Ann Arbor 29
Seattle 27
Jakarta 25
Shanghai 25
São Paulo 24
Princeton 23
Helsinki 21
Naples 21
Lappeenranta 20
Bologna 19
Boston 19
Woodbridge 19
Melbourne 18
Turin 18
Paris 17
Turku 16
Atlanta 15
Chicago 14
Medford 14
Abuja 12
Amsterdam 12
Toronto 12
Wilmington 12
Bengaluru 10
Orem 10
Cavriglia 8
Guangzhou 8
Phoenix 8
San Francisco 8
Shenzhen 8
Bari 7
Brescia 7
Brooklyn 7
Brussels 7
Cagliari 7
Haiphong 7
Montreal 7
Prato 7
Taipei 7
Thái Bình 7
Abidjan 6
Cairo 6
Catania 6
Curitiba 6
Da Nang 6
Johannesburg 6
Lecce 6
Mexico City 6
Palermo 6
Redondo Beach 6
San Diego 6
Stockholm 6
Ankara 5
Baghdad 5
Belo Horizonte 5
Denver 5
Guarulhos 5
Jeddah 5
Montelupo Fiorentino 5
Pittsburgh 5
Porto Alegre 5
Quito 5
Siena 5
Tashkent 5
Tianjin 5
Yubileyny 5
Totale 4.523
Nome #
Integration of CTA in the Diagnostic Workup of New Onset Chest Pain in Clinical Practice 239
Monoclonal Anti-PCSK9 Antibodies: Real-World Data 199
Transcatheter aortic valve implantation with core valve prosthesis: five year durability 193
Natural history of anti-PF4 antibodies in patients with vaccine-induced immune thrombocytopenia and thrombosis 192
Time, magnitude and patterns of left ventricular remodeling after MitraClip implantation: clinical implications 192
The serum metabolomic profiles of atrial fibrillation patients treated with direct oral anticoagulants or vitamin K antagonists 191
Cardiac involvement in eosinophilic granulomatosis with polyangiitis (formerly Churg-Strauss syndrome): Prospective evaluation at a tertiary referral centre 190
Impact of complete percutaneous revascularization in elderly patients with chronic total occlusion 176
Improving the net clinical benefit of dual/triple antithrombotic therapy in patients with atrial fibrillation and acute coronary syndrome: discovery and validation of prognostic factors for a tailored therapy 174
"Tailored" antiplatelet bridging therapy with cangrelor: moving toward personalized medicine. 170
Incidence of stroke in patients with hypertrophic cardiomyopathy in stable sinus rhythm during long-term monitoring 169
Emerging Medical Treatment for Hypertrophic Cardiomyopathy 169
TAVI for low-risk patients: comparison between patients enrolled in notion trial and in Florence real world registry 168
Paradoxical prolongation of QT interval during exercise in patients with hypertrophic cardiomyopathy: cellular mechanisms and implications for diastolic function 165
Prevalence, causes and predictors of cardiovascular hospitalization in patients with hypertrophic cardiomyopathy 162
Heparin induced thrombocytopenia: position paper from the Italian Society on Thrombosis and Haemostasis (SISET) 160
LDL-cholesterol target levels achievement in high-risk patients: An (un)expected gender bias 157
Machine learning approach for prediction of outcomes in anticoagulated patients with atrial fibrillation 156
Strength of clinical indication and therapeutic impact of the implantable cardioverter defibrillator in patients with hypertrophic cardiomyopathy 154
Impact of Pregnancy on the Natural History of Women with Hypertrophic Cardiomyopathy 154
Whole Exome Sequencing in Vaccine-Induced Thrombotic Thrombocytopenia (VITT) 153
The role of extracellular matrix and inflammation in the stratification of bleeding and thrombotic risk of atrial fibrillation on oral anticoagulant therapy: insights from Strat-Af study 152
Pathophysiology and Treatment of Hypertrophic Cardiomyopathy: New Perspectives 152
Heparin-induced thrombocytopenia after cardiac surgery. A single-center, retrospective cohort study 150
Antithrombotic Therapy in High Bleeding Risk, Part II: Noncardiac Percutaneous Interventions 150
Value of coronary CT angiography in women with stable chest pain in clinical practice 149
Implementation of low dose coronary CT angiography in the workflow for the assessment of new onset chest pain in clinical practice 148
Ex Vivo Antiplatelet Effects of Oral Anticoagulants 146
Adenosine in Interventional Cardiology: Physiopathologic and Pharmacologic Effects in Coronary Artery Disease 141
Association of different oral anticoagulants use with renal function worsening in patients with atrial fibrillation: A multicentre cohort study 139
Prevalence of Inherited Cardiac Diseases Among Young Patients Requiring Permanent Pacing 138
Digital droplet PCR versus quantitative PCR for lipoprotein (a) kringle IV type 2 repeat polymorphism genetic characterization 135
Clinical course and outcome of pregnancy in patients with hypertrophic cardiomyopathy 132
Clinical impact of high platelet reactivity in patients with atrial fibrillation and concomitant percutaneous coronary intervention on dual or triple antithrombotic therapy 129
Antithrombotic Therapy in High Bleeding Risk, Part I: Percutaneous Cardiac Interventions 128
Mavacamten, a Novel Therapeutic Strategy for Obstructive Hypertrophic Cardiomyopathy 127
Trombosi Iliaco femorale 126
MitraClip implantation in real-world: clinical relevance of different patterns of left ventricular remodeling 123
Left Ventricular Diastolic Dysfunction Predicts Global Longitudinal Strain Recovery after Surgical Aortic Valve Replacement 120
Markers of Inflammation and Hypofibrinolysis Are Associated with Cognitive Dysfunction and Motor Performances in Atrial Fibrillation Patients on Oral Anticoagulant Therapy: Insights from the Strat-AF Study 118
Relation between post-myocardial infarct remodelling and gelatinase activity in patients enrolled in the TIPTOP trial 117
Ischemic and bleeding risk by type 2 diabetes clusters in patients with acute coronary syndrome 113
Real-World Efficacy and Safety of Inclisiran: A Single-Country, Multicenter, Observational Study (CHOLINET Registry) 106
Lifetime Clinical Course of Hypertrophic Cardiomyopathy: Outcome of the Historical Florence Cohort Over 5 Decades 97
Pathophysiological and Molecular Basis of the Side Effects of Ticagrelor: Lessons from a Case Report 90
Lipoproteina(a) e rischio cardiovascolare: una roadmap per la gestione del paziente. Documento congiunto della Società Italiana per lo studio dell'Aterosclerosi (SISA), della Società Italiana di Cardiologia (SIC), della Associazione Nazionale Medici Cardiologi Ospedalieri (ANMCO) e di SIBioC 88
Lifetime Clinical Course of Hypertrophic Cardiomyopathy: Outcome of the Historical Florence Cohort Over 5 Decades 83
Familial hypercholesterolaemia in children and adolescents from 48 countries: a cross-sectional study 57
Eligibility for and practical implications of Semaglutide in overweight and obese patients with acute coronary syndrome 55
Atrial Fibrillation, Heart Failure Phenotypes, and Mortality Risk in the Nationwide START Registry: A Propensity Score Matching Analysis 49
Impact of adherence to a Mediterranean Diet pattern on patients with first acute myocardial infarction 44
Bicuspid Aortic Valve: Old and Novel Gene Contribution to Disease Onset and Complications 43
Lipoprotein(a) Genotype Influences the Clinical Diagnosis of Familial Hypercholesterolemia 41
Monitoring antiplatelet therapy: where are we now? 38
Refinement of the diagnostic approach for the identification of children and adolescents affected by familial hypercholesterolemia: Evidence from the LIPIGEN study 35
Disease trends over time and CD4 + CCR5 + T-cells expansion predict carotid atherosclerosis development in patients with systemic lupus erythematosus 33
Long-term left ventricular thrombosis resolution in patients receiving vitamin k antagonists: a multicenter observational study 29
Applicability of the 2013 ACC/AHA Risk Assessment and Cholesterol Treatment Guidelines in the real world: results from a multiethnic case-control study 27
Effect of adherence to Mediterranean diet on first ST-elevation myocardial infarction: Insights from multiethnic case-control study 23
Inappropriate Underdosing of Direct Oral Anticoagulants in Atrial Fibrillation Patients: Results from the START2-AF Registry 21
PCSK9-Targeting Drugs and Gender: Are There Any Differences? 20
Pleiotropic Effects of Oral Anticoagulant Therapy: Is There a Difference Between VKAs and DOACs? 19
Serum uric acid on admission predicts in-hospital mortality in patients with acute coronary syndrome 16
The predictive role of renal function and systemic inflammation on the onset of de novo atrial fibrillation after cardiac surgery 13
A combination of 2 rapid immunoassays significantly improves diagnostic sensitivity for heparin-induced thrombocytopenia 9
Totale 7.552
Categoria #
all - tutte 21.685
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 21.685


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202118 0 0 0 0 0 0 0 0 0 0 0 18
2021/2022201 17 6 5 13 6 14 0 8 15 18 37 62
2022/2023479 35 117 24 25 15 72 69 25 63 10 17 7
2023/2024308 8 22 31 13 23 37 20 60 9 49 29 7
2024/20252.416 80 223 147 370 543 350 108 157 122 68 100 148
2025/20263.864 317 496 409 321 463 133 421 180 242 233 252 397
Totale 7.552